	Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. Eur Urol Focus Cheng HH, Callis S, Yu EY, Delacroix SE, Sokolova AO, Tangen CM, Lerner SP, Dorff TB, Lin DW. PMID: 41354605 [PubMed - as supplied by publisher]
	Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions. Eur Urol Focus Al-Khanaty A, Hennes D, Perera ML, Lawrentschuk N, Murphy DG, Eapen RS. PMID: 41354604 [PubMed - as supplied by publisher]
	Androgen deprivation therapy with apalutamide in the treatment of metastatic castration-sensitive prostate cancer: the systematic review of its effectiveness and applicability for Asian men in the targeted investigational treatment analysis of novel anti-androgen (TITAN) trial. Int Urol Nephrol Yang F, Feng L, Liu W, Liang S. PMID: 41353294 [PubMed - as supplied by publisher]
	A novel angiogenesis-related gene signature predicting prognosis in clear cell renal cell carcinoma. Sci Rep Xu YY, Cheng GB, Li XY, Zeng XX, Wu SY. PMID: 41353246 [PubMed - as supplied by publisher]
	Proteome-wide association study of prostate cancer risk across populations. Nat Commun Zhong H, Zhu J, Liu S, Wu C, Wang L, Whelton SP, Marshall CH, Blaha MJ, Durda P, Guo X, Johnson CW, Lin HJ, Taylor KD, Tracy RP, Yarden RI, Manichaikul AW, Rich SS, Rotter JI, Deo R, Dubin RF, Ganz P, Wu L. PMID: 41353205 [PubMed - as supplied by publisher]
	PARP Inhibitors in Prostate Cancer: Broad Use or Patient Selection? Eur Urol Focus González-Ginel I, Rodriguez-Antolin A, Olmos D, Castro E. PMID: 41353049 [PubMed - as supplied by publisher]
	Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Eur Urol Oncol Bianchi L, Droghetti M, Catanzaro C, Valerio M, Novello Q, Mari A, Campi R, Nicoletti R, Heidegger I, Giannini G, Zattoni F, Reitano G, Bauckneht M, Lanfranchi F, Rajwa P, Marra G, Soeterik T, den Bergh RV, Fendler WP, Darr C, Rivas JG, Kesch C, Mignogna C, Gandaglia G, Ceci F, Farolfi A, Gontero P, Fanti S, Masieri L, Serni S, Minervini A, Briganti A, Montorsi F, Schiavina R. PMID: 41353037 [PubMed - as supplied by publisher]
	Targeting MAO offers a novel immunotherapeutic strategy for prostate cancer by modulating the "tumor-stroma-immune" interaction network. Biochim Biophys Acta Rev Cancer Hu Y, Zhao Z, Ma Y, He X, Shi C. PMID: 41352489 [PubMed - as supplied by publisher]
	The role of manufacturer and user facility database in evaluating BPH and prostate cancer procedures. World J Urol Chughtai B, Venkatraman G, Gressler L, Elterman D, Bhojani N. PMID: 41351682 [PubMed - indexed for MEDLINE]
	Histone Modification Networks Reshape the Metabolism and Treatment Landscape of Urological Cancers. Front Biosci (Landmark Ed) Liu F, He L, Yu M, Chen J, Huang Y, Ma W, Wan Y, Zhou B. PMID: 41351419 [PubMed - indexed for MEDLINE]
	Developing a prediction model in a large case-control study for the early detection of bladder cancer. J Transl Med Tanaka S, Wilkens LR, Marchand LL, Yang G, Yuan JM, Koh WP, Shrubsole MJ, Luu M, Pagano I, Figueiredo JC, Furuya H, Rosser CJ. PMID: 41351005 [PubMed - as supplied by publisher]
	Preoperative predictors about lymph node metastasis and biochemical recurrence in high-risk prostate cancer patients: a clinic pathological retrospective study. BMC Urol Wang C, Wang G, Xiao L, Du H, Xu Y, Li S, Yang X. PMID: 41350993 [PubMed - as supplied by publisher]
	Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT Reports. Mol Imaging Biol Ismayilov R, Aktas A, Gencoglu EA, Oguz A, Altundag O, Akcali Z. PMID: 41350971 [PubMed - as supplied by publisher]
	Infection risks and biopsy-associated complications in prostate cancer diagnosis: a review of recent literatures. Prostate Cancer Prostatic Dis Nikolaevich PV, Samuel AO, Fayazovich UM, Olaiya VO, Adesegun FA. PMID: 41350942 [PubMed - as supplied by publisher]
	Comparison of Retzius-sparing versus anterior robotic-assisted radical prostatectomy in patients with prior transurethral resection of the prostate (TURP). World J Urol Schütz V, Hatiboglu G, Würkner D, Tekesin M, Feisst M, Duensing S, Huber J, Hohenfellner M, Kaufmann B. PMID: 41350773 [PubMed - indexed for MEDLINE]
	Prostate Cancer: Current Status of Novel Molecular Imaging and Future Prospects. Eur Urol Focus Wunsch DC 3rd, Turkbey B. PMID: 41350193 [PubMed - as supplied by publisher]
	Pituitary Metastasis from Renal Cell Carcinoma: Case Report, Systematic Review, and Worldwide Distribution Analysis. Neurocirugia (Engl Ed) García-Nájera AR, Vásquez-Rafael C, Benítez-Rodríguez FJ, García-Nájera O, Gamboa-Jiménez TI, Martínez-Pineda W, Vergara-Juárez J, Armas-Salazar A, Carrillo-Ruiz JD, Jiménez-Ponce F, Beltrán JQ. PMID: 41349924 [PubMed - as supplied by publisher]
	Immune checkpoint inhibition in renal cell carcinoma: Mechanisms of resistance and emerging therapeutic strategies. Biomed Pharmacother Darzi A, Shokouhfar M, Farajee N, Ghafari A, Deldar F, Eini P, Vanan AG, Bahrami N. PMID: 41349248 [PubMed - as supplied by publisher]
	Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints. J Urol Shore ND, De Giorgi U, Tutrone RF, Bailen JL, Roos EP, Kliment J, Marx G, Karsh LI, Ramirez-Backhaus M, Uchio EM, Supiot S, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. PMID: 41349040 [PubMed - as supplied by publisher]
	Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment. PLoS One Frey LJ, Banasiewicz KE, Ruckes C, Wagner I, Haack M, Mager R, Juengel E, Haferkamp A, Duwe G, Brandt MP. PMID: 41348715 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 174299

Page 1 of 8715



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy